ClinicalTrials.gg
CompletedNCT05022836Updated Sep 1, 2021

Four-limb Blood Pressures in Infants With High Risk of Congenital Malformation of Aorta

An observational study in Congenital Heart Disease in Children, Coarctation of Aorta and Interrupted Aortic Arch, sponsored by Guangdong Provincial People's Hospital. Completed. Open to participants aged 0 Days to 1 Year. Per ClinicalTrials.gov, last updated 2021-09-01.

Sponsored by Guangdong Provincial People's Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,604
Ages
0 Days to 1 Year
Sex
All
01

Study summary

Pulse oximetry screening (POS) for critical congenital heart diseases (CCHD) could identify 90% of these infants. However, this approach is not designed to detect cardiac defects without hypoxemia, especially congenital malformations of aorta (CMoA). More than 60% of CMoA was late diagnosed.

Infants with CMoA were supposed to present with blood pressure (BP) gradient between four limbs. But a large sample size retrospective study of four-limb BP screening showed a negative result. The possible reason is that this study ran in population with a very low risk of CMoA. Whether four-limb BPs measurement could be used in infants with high risk of congenital malformation of aorta is still to be determined.

The investigators retrospectively collected four-limb BPs, which was prospectively measured, in infants with high risk of CMoA. These data were divided into two groups, the discovery group and the validation group. The best cutoff of four-limb BP gradient was generated by Youden Index. The BP gradients by age were analyzed. Pre-operative hypotension and post-operative hypertension were also analyzed.

02

Conditions studied

  • Congenital Heart Disease in Children
  • Coarctation of Aorta
  • Interrupted Aortic Arch
  • Hypoplasia of Aorta
  • Blood Pressure

Keywords

  • Congenital Heart Disease
  • Coarctation of Aorta
  • Interrupted Aortic Arch
  • Hypoplasia of Aorta
  • Blood Pressure
  • screening
03

In context

Aortic Coarctation

49 studies on the registry are indexed under Aortic Coarctation; 16 are open to participants now.

This study's enrollment of 1,604 is above the median of 100 across 29 observational studies indexed under Aortic Coarctation.

Browse Aortic Coarctation studies →

Lead sponsor

Guangdong Provincial People's Hospital is the lead sponsor of 237 studies on the registry; 102 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Days to 1 Year
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Infants admitted to the Guangdong Provincial People's Hospital between January 1st, 2013 and December 31st, 2019, who were suspected as having congenital heart disease, were enrolled in the study. Four-limb BPs in infants of confirmed or suspected CCHD admitted at our hospital were prospectively collected at admission following the Pediatric Department protocol for CCHD infants in which all infants with high risk of CCHD, defined as confirmed or suspected CCHD by clinical teams, were screened by measuring four-limb BPs by certificated nurses. Suspected CCHD was defined as unreasonable low SpO2, cyanosis, murmur, suspected CHD by prenatal ultrasound or postnatal echocardiography at other hospitals, and unexplained poor cardiac output.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants admitted to the Guangdong Provincial People's Hospital between January 1st, 2013 and December 31st, 2019, who were suspected as having congenital heart disease, were enrolled in the study.

Exclusion criteria

Exclusion Criteria:

  • Infants without four-limb blood pressures measurement or without echocardiogram and cardiac computed tomography results were excluded.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,604 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testfour-limb blood pressure measurements

    Four-limb blood pressures were measured by certificated nurses at admission.

    Also known as: Echocardiogram or cardiac computed tomography results were used as the gold standard.

06

What researchers measure

Primary outcomes

  1. The cutoff of four-limb BPs gradient to diagnose CMoA

    ROC curve and Youden Index were used in the discovery group and the validation group to spot the optimal cutoff of BP gradient.

    Time frame: at admission

Secondary outcomes

  1. The accuracy of four-limb BPs measurement to predict CMoA

    The sensitivity, specificity, Youden index, the area under the ROC curve, likelihood ratio for positive test results, likelihood ratio for negative test results, positive predictive value, and negative predictive value were calculated.

    Time frame: at admission

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2013 to primary completion in Dec 2019, 83 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 20, 2021
First posted
Aug 26, 2021
StartActual
Jan 1, 2013
Primary completionActual
Dec 31, 2019
CompletionActual
Jun 25, 2021
Last update
Sep 1, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 1, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05022836
Responsible party
Yifei WANG (Deputy director of the Neonatology Department, Principal Investigator, Guangdong Provincial People's Hospital) — Principal investigator
First posted
Aug 26, 2021
Start date
Jan 1, 2013
Primary completion
Dec 31, 2019
Completion
Jun 25, 2021
Last update
Sep 1, 2021

Study contacts

Yifei Wang, MD
principal investigator · Guangdong Provincial People's Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion